N 343 2.5
Pill imprint N 343 2.5 has been identified as Glyburide 2.5 mg.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy.
Glyburide 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Glyburide Images
- Imprint:
-
N 343
2.5 - Strength:
- 2.5 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
silicon dioxide colloidal
magnesium stearate
FD&C Yellow No. 6
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-8343
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0872 | UDL Laboratories Inc |
| 63739-0118 | McKesson Packaging Services |
| 66336-0028 | Dispensing Solutions Inc. (repackager) |
| 67544-0875 | Prepak Systems Inc (repackager) |
| 23490-5638 | Palmetto State Pharmaceuticals Inc (repackager) |
| 35356-0360 | Lake Erie Medical and Surgical Supply (repackager) |
| 55289-0606 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glyburide resources
- Glyburide
- Glyburide (Wolters Kluwer)
- Glyburide Tablets (Micronized) (Wolters Kluwer)
- glyburide (Cerner Multum)
- Euglucon (Micromedex) - Includes Dosage Information
- glyburide (Micromedex) - Includes Dosage Information
- Glyburide (AHFS DI)
- Glyburide Micronized (FDA)
- Glyburide Tablets (FDA)
- Glyburide (Wolters Kluwer)
Search Again
